Key result
Novel oral anticoagulants could provide safe, efficacious, and convenient alternatives to warfarin for preventing stroke in older people with atrial fibrillation.
Why the study?
Do novel oral anticoagulants provide a safe and effective alternative to warfarin for preventing stroke in older people with non-valvular atrial fibrillation?
Do novel oral anticoagulants provide a safe and effective alternative to warfarin for preventing stroke in older people with non-valvular atrial fibrillation?
Novel oral anticoagulants offer a safe, effective, and convenient alternative to warfarin for stroke prevention in older patients with non-valvular atrial fibrillation.
No takes yet. Share an insight, caveat, or question.
May support NOAC preference over warfarin in older nonvalvular AF; leaves open need for dedicated RCTs.
Grewal et al. (2012) conducted a review in Non-valvular atrial fibrillation. Novel oral anticoagulants (direct thrombin inhibitors and factor Xa inhibitors) vs. Warfarin was evaluated. Novel oral anticoagulants could provide safe, efficacious, and convenient alternatives to warfarin for preventing stroke in older people with atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: